Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 21:05:10 - browse：1526

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： New menopause drug shows promise in relief for hot flashes

WSS

A cyberattack has disrupted hospitals and health care in several states

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Generative AI mines health records to identify patients’ social needs

ER docs worry over extreme heat as a 'mass casualty event'

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Idaho abortion case may prompt more restrictions in other states

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Activists slam private health insurers over coverage restrictions

Gilgo Beach: Police identify another victim in serial killing investigation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Influencer to be charged after chaos erupts in New York City's Union Square

BioMarin wins approval for gene therapy to treat hemophilia A

Idaho abortion case may prompt more restrictions in other states

Activists slam private health insurers over coverage restrictions

My superpower is killing ticks

DIEP, the 'gold standard' of breast reconstruction, is under threat

ProMED, early warning system on disease outbreaks, in peril

hotspot

Stem cell clinics for heart failure: buyer be wary

New menopause drug shows promise in relief for hot flashes

Verily hires former Apple Health leader as chief scientific officer

Verily hires former Apple Health leader as chief scientific officer

Doulas covered by Medicaid under New York's new plan

GSK to buy asthma

focus

focus

hotspot

focus